The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients With Severe Sepsis
Clinical trial NCT00045760 · COMPLETED
Trial details
- NCT number
- NCT00045760
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.